PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,016,000 | -62.7% | 313,466 | -72.2% | 0.10% | -41.7% |
| Q3 2018 | $2,721,000 | -9.5% | 1,129,121 | +4.8% | 0.16% | -24.9% |
| Q2 2018 | $3,006,000 | -42.7% | 1,077,408 | -2.5% | 0.22% | -56.5% |
| Q1 2018 | $5,248,000 | -40.0% | 1,104,940 | -26.3% | 0.50% | -65.8% |
| Q4 2017 | $8,745,000 | – | 1,500,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |